Free Trial

Lichen International (LICN) Competitors

Lichen International logo
$7.28 -1.11 (-13.22%)
As of 03:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.

LICN vs. ZBAI, SFHG, AWX, BIAF, and RVYL

Should you buy Lichen International stock or one of its competitors? MarketBeat compares Lichen International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Lichen International include ATIF (ZBAI), Samfine Creation Holdings Group (SFHG), Avalon (AWX), bioAffinity Technologies (BIAF), and Ryvyl (RVYL). These companies are all part of the "business services" industry.

How does Lichen International compare to ATIF?

Lichen International (NASDAQ:LICN) and ATIF (NASDAQ:ZBAI) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends.

ATIF has lower revenue, but higher earnings than Lichen International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lichen International$24.52M0.18-$21.96MN/AN/A
ATIF$1.20M9.85-$4.60M-$7.19N/A

Company Net Margins Return on Equity Return on Assets
Lichen InternationalN/A N/A N/A
ATIF N/A N/A N/A

Lichen International has a beta of -0.88, meaning that its share price is 188% less volatile than the broader market. Comparatively, ATIF has a beta of 0.08, meaning that its share price is 92% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lichen International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
ATIF
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, ATIF had 4 more articles in the media than Lichen International. MarketBeat recorded 6 mentions for ATIF and 2 mentions for Lichen International. Lichen International's average media sentiment score of 0.81 beat ATIF's score of 0.24 indicating that Lichen International is being referred to more favorably in the media.

Company Overall Sentiment
Lichen International Positive
ATIF Neutral

Summary

ATIF beats Lichen International on 4 of the 6 factors compared between the two stocks.

How does Lichen International compare to Samfine Creation Holdings Group?

Samfine Creation Holdings Group (NASDAQ:SFHG) and Lichen International (NASDAQ:LICN) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

Company Net Margins Return on Equity Return on Assets
Samfine Creation Holdings GroupN/A N/A N/A
Lichen International N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Samfine Creation Holdings Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Lichen International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Samfine Creation Holdings Group and Samfine Creation Holdings Group both had 2 articles in the media. Samfine Creation Holdings Group's average media sentiment score of 1.45 beat Lichen International's score of 0.81 indicating that Samfine Creation Holdings Group is being referred to more favorably in the media.

Company Overall Sentiment
Samfine Creation Holdings Group Positive
Lichen International Positive

Samfine Creation Holdings Group has higher earnings, but lower revenue than Lichen International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Samfine Creation Holdings Group$21.82M0.48-$2.55MN/AN/A
Lichen International$24.52M0.18-$21.96MN/AN/A

Samfine Creation Holdings Group has a beta of 2.09, indicating that its stock price is 109% more volatile than the broader market. Comparatively, Lichen International has a beta of -0.88, indicating that its stock price is 188% less volatile than the broader market.

Summary

Samfine Creation Holdings Group beats Lichen International on 4 of the 5 factors compared between the two stocks.

How does Lichen International compare to Avalon?

Avalon (NYSE:AWX) and Lichen International (NASDAQ:LICN) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

Avalon has a net margin of 1.17% compared to Lichen International's net margin of 0.00%. Avalon's return on equity of 2.72% beat Lichen International's return on equity.

Company Net Margins Return on Equity Return on Assets
Avalon1.17% 2.72% 1.10%
Lichen International N/A N/A N/A

34.4% of Avalon shares are owned by institutional investors. 20.0% of Avalon shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avalon
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Lichen International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Lichen International had 1 more articles in the media than Avalon. MarketBeat recorded 2 mentions for Lichen International and 1 mentions for Avalon. Lichen International's average media sentiment score of 0.81 beat Avalon's score of 0.00 indicating that Lichen International is being referred to more favorably in the news media.

Company Overall Sentiment
Avalon Neutral
Lichen International Positive

Avalon has higher revenue and earnings than Lichen International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avalon$85.14M0.12-$1.77M$0.1516.83
Lichen International$24.52M0.18-$21.96MN/AN/A

Avalon has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market. Comparatively, Lichen International has a beta of -0.88, suggesting that its stock price is 188% less volatile than the broader market.

Summary

Avalon beats Lichen International on 8 of the 12 factors compared between the two stocks.

How does Lichen International compare to bioAffinity Technologies?

bioAffinity Technologies (NASDAQ:BIAF) and Lichen International (NASDAQ:LICN) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

bioAffinity Technologies has a beta of -1.19, meaning that its share price is 219% less volatile than the broader market. Comparatively, Lichen International has a beta of -0.88, meaning that its share price is 188% less volatile than the broader market.

Lichen International has a net margin of 0.00% compared to bioAffinity Technologies' net margin of -280.53%. Lichen International's return on equity of 0.00% beat bioAffinity Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
bioAffinity Technologies-280.53% -285.75% -143.71%
Lichen International N/A N/A N/A

bioAffinity Technologies has higher earnings, but lower revenue than Lichen International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$6.16M1.38-$14.91M-$11.77N/A
Lichen International$24.52M0.18-$21.96MN/AN/A

In the previous week, bioAffinity Technologies had 2 more articles in the media than Lichen International. MarketBeat recorded 4 mentions for bioAffinity Technologies and 2 mentions for Lichen International. bioAffinity Technologies' average media sentiment score of 0.81 beat Lichen International's score of 0.81 indicating that bioAffinity Technologies is being referred to more favorably in the media.

Company Overall Sentiment
bioAffinity Technologies Positive
Lichen International Positive

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
bioAffinity Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Lichen International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

1.6% of bioAffinity Technologies shares are owned by institutional investors. 2.7% of bioAffinity Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

bioAffinity Technologies beats Lichen International on 6 of the 11 factors compared between the two stocks.

How does Lichen International compare to RTB Digital, Inc. Common Stock?

Lichen International (NASDAQ:LICN) and RTB Digital, Inc. Common Stock (NASDAQ:RTB) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

In the previous week, RTB Digital, Inc. Common Stock had 4 more articles in the media than Lichen International. MarketBeat recorded 6 mentions for RTB Digital, Inc. Common Stock and 2 mentions for Lichen International. Lichen International's average media sentiment score of 0.81 beat RTB Digital, Inc. Common Stock's score of -0.19 indicating that Lichen International is being referred to more favorably in the media.

Company Overall Sentiment
Lichen International Positive
RTB Digital, Inc. Common Stock Neutral

RTB Digital, Inc. Common Stock has lower revenue, but higher earnings than Lichen International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lichen International$24.52M0.18-$21.96MN/AN/A
RTB Digital, Inc. Common Stock$11.13M0.69-$17.53M-$36.37N/A

17.4% of RTB Digital, Inc. Common Stock shares are held by institutional investors. 12.4% of RTB Digital, Inc. Common Stock shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lichen International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
RTB Digital, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Company Net Margins Return on Equity Return on Assets
Lichen InternationalN/A N/A N/A
RTB Digital, Inc. Common Stock N/A N/A -46.12%

Lichen International has a beta of -0.88, indicating that its stock price is 188% less volatile than the broader market. Comparatively, RTB Digital, Inc. Common Stock has a beta of 2.72, indicating that its stock price is 172% more volatile than the broader market.

Summary

RTB Digital, Inc. Common Stock beats Lichen International on 7 of the 10 factors compared between the two stocks.

Get Lichen International News Delivered to You Automatically

Sign up to receive the latest news and ratings for LICN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LICN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LICN vs. The Competition

MetricLichen InternationalFIN IndustryFinance SectorNASDAQ Exchange
Market Cap$4.40M$6.97B$13.34B$12.32B
Dividend YieldN/A5.76%5.84%5.35%
P/E RatioN/A89.3323.0325.37
Price / Sales0.1812.25173.8273.28
Price / CashN/A74.2620.4556.33
Price / Book0.062.562.126.93
Net Income-$21.96M$301.20M$1.11B$333.88M
7 Day Performance5.83%-2.36%-1.49%0.33%
1 Month Performance37.38%0.25%-0.61%2.11%
1 Year Performance37.12%17.53%9.70%33.31%

Lichen International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LICN
Lichen International
1.1532 of 5 stars
$7.28
-13.2%
N/A+42.9%$4.40M$24.52MN/A390
ZBAI
ATIF
0.2405 of 5 stars
$8.26
+7.3%
N/A-49.5%$10.19M$1.20MN/A10
SFHG
Samfine Creation Holdings Group
1.1073 of 5 stars
$2.48
-0.8%
N/A-38.6%$10.15M$21.82MN/AN/A
AWX
Avalon
N/A$2.53
-1.2%
N/A+5.9%$9.86M$83.55M10.12610
BIAF
bioAffinity Technologies
0.2353 of 5 stars
$1.98
-2.0%
N/A-70.5%$9.09M$6.11MN/A10

Related Companies and Tools


This page (NASDAQ:LICN) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners